fda stance on bpc 157 NBC News | The claims surrounding peptides are sweeping: They're promoted as treatments for everything from faster healing to younger-looking skin, FDA Advisers Vote to Ease

Skipping rehabilitation may result in healed but weak tissue prone to re-injury

In contrast, animals treated with 200 M neomycin for thirty minutes exhibit dim or completely absent fluorescence

The 2025 paper is the most recent significant independent confirmation of the in vitro mechanistic claims about Epithalon and represents the kind of external replication that the Epithalon literature had previously lacked

Evidence-based levers that reliably move the needle: A sustainable calorie deficit with adequate protein Resistance training plus daily movement Sleep and stress management (often underestimated) Clinician-guided options when appropriate, including FDA-approved obesity medications (e.g., Wegovy and Zepbound ) and weight loss injections A good rule of thumb: don't outsource a fundamentals problem to an unproven tool

MOR activation reduces GABA, but not glutamate input to primary cells (Pan et al., 1990, 2000)